Amisulpride : List of nationally authorised medicinal products - PSUSA/00000167/202301

Opinion/decision on a Paediatric investigation plan (PIP): Elfabrio,Pegunigalsidase alfa, decision type: , therapeutic area: , PIP number: P/0290/2022

Cisplatin : List of nationally authorised medicinal products - PSUSA-00000778-202212

Human medicines European public assessment report (EPAR): Adempas, riociguat, Hypertension, Pulmonary, Date of authorisation: 27/03/2014, Revision: 13, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): emtricitabine,rilpivirine,tenofovir alafenamide, decision type: , therapeutic area: , PIP number: P/0356/2022

Opinion/decision on a Paediatric investigation plan (PIP): Ronapreve,Imdevimab, decision type: , therapeutic area: , PIP number: P/0343/2022

Opinion/decision on a Paediatric investigation plan (PIP): Vamorolone, decision type: , therapeutic area: , PIP number: P/0295/2022

Opinion/decision on a Paediatric investigation plan (PIP): Ronapreve,Casirivimab, decision type: , therapeutic area: , PIP number: P/0300/2022

Opinion/decision on a Paediatric investigation plan (PIP): Vydura,Rimegepant, decision type: , therapeutic area: , PIP number: P/0299/2022

Opinion/decision on a Paediatric investigation plan (PIP): Hepcludex,Bulevirtide, decision type: , therapeutic area: , PIP number: P/0270/2022